Detalhe da pesquisa
1.
Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells.
J Immunol
; 198(4): 1585-1594, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062698
2.
CAR-Expressing Natural Killer Cells for Cancer Retargeting.
Transfus Med Hemother
; 46(1): 4-13, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31244577
3.
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.
Br J Haematol
; 180(6): 808-820, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468712
4.
Antibody Isotypes for Tumor Immunotherapy.
Transfus Med Hemother
; 44(5): 320-326, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070977
5.
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.
Transfus Med Hemother
; 44(5): 292-300, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070974
6.
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.
Br J Haematol
; 181(3): 413-417, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449349
7.
Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice.
Exp Anim
; 68(1): 1-11, 2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078790
8.
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.
Front Immunol
; 9: 2408, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405611
9.
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo.
Cancer Res
; 76(2): 403-17, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26634925